Dr. Peter George Bittar, MD

Dr. Bittar practices at Integrated Dermatology of South Miami in Boca Raton, Florida.

Dr. Bittar's NPI, 1811489784, was assigned on June 5, 2018. Dr. Bittar graduated from Duke University School of Medicine in 2018. Dr. Bittar holds Florida license ME159509.

Dr. Bittar's primary practice is Integrated Dermatology of South Miami, at 4700 Exchange Ct, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (305) 279-6060.

Dr. Bittar's primary practice is Integrated Dermatology of South Miami in Boca Raton, Florida. Dr. Bittar is also affiliated with Geisinger Medical Center. The medical group on file is Integrated Dermatology. Dmand AI also links Dr. Bittar to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bittar practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Bittar's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Bittar is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bittar's licenses on file in 4 states: Florida, Indiana, New York and Connecticut.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, skin cyst and skin discoloration among the conditions Dr. Bittar treats.

CMS data shows 1,366 Medicare services from Dr. Bittar across 21 procedure codes in 2024, for 300 Medicare patients. Medicare paid $182,101 for them. Every service was in an office.

CMS counts 300 Medicare patients who saw Dr. Bittar in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bittar's median patient age at 57, with 48% women.

In 2024, Dr. Bittar wrote 292 Medicare Part D claims for 130 patients. 93% of them were for generic drugs. CMS names the drug for 228 of them, across 8 drugs with 11 or more claims each, at $5,274 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

Dr. Bittar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bittar as offering telehealth. CMS counts 315 procedures of removal of skin lesions by Dr. Bittar, more than 82% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Bittar, published from 2017 to 2024. 2017 was the busiest year, with 7. The most frequent topics are Skin Neoplasms, Mohs Surgery and Melanoma. Dr. Bittar has published most often in Dermatol Surg. Dr. Bittar's most frequent co-authors are Jeremy R. Etzkorn, MD, Thuzar Myo Shin, MD and Joseph F. Sobanko.

CMS Open Payments shows 92 general payments to Dr. Bittar from 19 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $921.

Dmand AI lists 1 award for Dr. Bittar, most recently Gold Humanism Honor Society in 2019.

Dr. Bittar graduated from Duke University School of Medicine in 2018.

Dr. Bittar is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.